Dr. Dongli Song is Attending Neonatologist and Director of Newborn Clinical Research at Santa Clara Valley Medical Center and holds an Affiliated Pediatric Clinical at Stanford University School of Medicine.
She earned her MD from Beijing Medical University – now renamed as Peking University Health Science Center and her PhD in Molecular and Medical Genetics at University of Toronto. She received her pediatric training and research at New York University, Stanford University and University of California, San Francisco (UCSF).
Dr. Song is committed to bridging the gap between clinical needs, basic research and biotechnology, focusing on innovative medical therapies for brain maturation, early diagnosis and intervention for brain injuries. She has led and contributed to numerous multicenter clinical trials, including pioneering research in hypothermia therapy for neonatal hypoxic-ischemic encephalopathy (HIE), oral somatosensory stimulation in preterm infants, and maternal-fetal COVID-19 transmission.